0
Insider buys, 6 months
1
Congress trades, 6 months
0
Signals, 6 months
Six months
This chart is shown by TradingView, which receives your IP address when it loads.
After each filing
9
May 8
Sale
Sen. John Boozman
Senate
1 week
+0.1%S&P −0.1%
1 month
+0.3%S&P −1.9%
3 months
+0.9%S&P +4.5%
6 months
Result in11 trading days
Feb 15
Buy
Sen. John Boozman
Senate
1 week
+0.1%S&P +0.7%
1 month
+0.3%S&P −3.1%
3 months
+0.8%S&P +8.5%
6 months
+1.8%S&P +13.0%
Jan 13
Sale
Sen. John Boozman
Senate
1 week
+0.1%S&P −0.2%
1 month
+0.3%S&P −1.2%
3 months
+0.9%S&P +1.9%
6 months
+1.8%S&P +8.2%
Sep 12, 2025
Sale
Sen. John Boozman
Senate
1 week
+0.1%S&P +1.2%
1 month
+0.3%S&P +0.5%
3 months
+1.0%S&P +3.4%
6 months
+1.9%S&P +2.1%
Jul 9, 2025
Buy
Sen. John Boozman
Senate
1 week
+0.1%S&P +0.4%
1 month
+0.4%S&P +1.8%
3 months
+1.1%S&P +7.9%
6 months
+2.1%S&P +10.8%
Show all 9
Jun 14, 2025
Sale
Sen. John Boozman
Senate
1 week
+0.1%S&P +1.0%
1 month
+0.4%S&P +4.5%
3 months
+1.2%S&P +9.8%
6 months
+2.1%S&P +13.6%
Apr 20, 2025
Buy
Sen. John Boozman
Senate
1 week
+0.1%S&P +7.2%
1 month
+0.3%S&P +15.4%
3 months
+1.0%S&P +22.7%
6 months
+2.1%S&P +31.4%
Mar 6, 2025
Buy
Sen. John Boozman
Senate
1 week
+0.1%S&P −2.3%
1 month
+0.4%S&P −12.2%
3 months
+1.0%S&P +4.3%
6 months
+2.2%S&P +13.3%
Feb 8, 2025
Buy
Sen. John Boozman
Senate
1 week
+0.1%S&P +1.1%
1 month
+0.4%S&P −7.6%
3 months
+1.0%S&P −3.3%
6 months
+2.1%S&P +6.9%
Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.
Filings for TBLL
11 held · newest 511 held · newest 2Loading the filings.
Aeon news and offers by email
New sources, new features and offers like our founding price. A few times a month at most. Stop any time.
Government contracts, last 12 months
Awards of $10M and up, from USAspending · context, not a signalNo contracts of $10M or more in the last 12 months.
Lobbying
Last four quartersNo lobbying reports on file.